Your browser doesn't support javascript.
loading
Do the Words We Choose Matter When Prescribing Medications?
J Drugs Dermatol ; 22(12): 1216-1219, 2023 Dec 01.
Article en En | MEDLINE | ID: mdl-38051863
ABSTRACT

BACKGROUND:

Caregivers are often apprehensive about treating childhood atopic dermatitis (AD) with topical corticosteroids but may find comfort if treatments are presented in a patient-centered manner.

OBJECTIVE:

We assessed caregivers' willingness to treat AD with either a "topical steroid," "topical medication," or "treatment, similar to the all-natural signals produced by the adrenal glands in the body."

METHODS:

A survey randomized 874 caregivers of children with AD to receive a "topical steroid," "topical medication," or "treatment, similar to the all-natural signals produced by the adrenal glands in the body." A scenario-only dataset received these descriptions, while a descriptive heading dataset and expanded scale dataset also received headings of "Topical Steroid Use," "Topical Medication Use," and "All-Natural Treatment Use," respectively. Responses were recorded on a 6-point Likert scale or 0-100 slider scale. Whole and dichotomized responses were evaluated using 2-tailed, independent sample t-tests.

RESULTS:

For the descriptive heading and expanded scale datasets, those presented with a "topical medication" reported greater willingness to treat than those presented with a "topical steroid" and "all-natural treatment" in the descriptive heading dataset (P<0.05). For the dichotomized scenario-only dataset, those presented with a "treatment, similar to the all-natural signals produced by the adrenal glands in the body," reported greater willingness than those presented with a "topical medication" (P<0.05).

CONCLUSION:

Initially presenting caregivers with a "topical medication" rather than a "topical steroid" may improve willingness to treat AD for some caregivers. However, tailoring the discussion to best fit caregiversunderstanding of treatment may be the most beneficial approach. J Drugs Dermatol. 2023;22(12)1216-1219. doi10.36849/JDD.5746.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dermatitis Atópica / Fármacos Dermatológicos Límite: Child / Humans Idioma: En Revista: J Drugs Dermatol Asunto de la revista: DERMATOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dermatitis Atópica / Fármacos Dermatológicos Límite: Child / Humans Idioma: En Revista: J Drugs Dermatol Asunto de la revista: DERMATOLOGIA Año: 2023 Tipo del documento: Article